Elsevier partners with the Society for Mucosal Immunology to publish Mucosal Immunology | News Direct

Elsevier partners with the Society for Mucosal Immunology to publish Mucosal Immunology This collaboration paves the way for transitioning the journal to a gold open access publication model

News release by Elsevier

facebook icon linkedin icon twitter icon pinterest icon email icon Amsterdam | July 18, 2022 04:00 AM Eastern Daylight Time

 

The Society for Mucosal Immunology (SMI), the preeminent international community of researchers working together to advance the field of mucosal immunology and improve health worldwide, and Elsevier, a global leader in research publishing and information analytics, are delighted to announce a new partnership to publish SMI’s official journal, Mucosal Immunology. The journal will transition to gold open access, making articles immediately and permanently available for everyone to read, download, copy and distribute. It will be hosted on Elsevier’s leading online platform, ScienceDirect, beginning January 2023.

SMI’s decision to partner with Elsevier furthers its ongoing mission to directly support research and education and foster communication and collaboration in the field of mucosal immunology. Transitioning its journal from its current subscription model to gold open access clearly reflects its commitment to make its content more easily accessible and drive innovation in the field.

SMI President Michael McGuckin, PhD, said: “We welcome Elsevier as our new publisher and look forward to taking advantage of its publishing expertise and commitment to open science as we continue our journey to increase the visibility and influence of Mucosal Immunology together. It is clear from our early interactions with Elsevier staff and leadership that this will be a partnership in the truest sense of the word and enable us to build upon the journal’s high standards and further enhance its global prominence.”

Since 1990, mucosal immunology has expanded from what many considered a niche discipline to one of the hottest areas in immunobiology today, underpinned by interactions with the microbiome and nervous system that have profound implications for health and disease. The journal fosters cross-fertilization between scientists, clinical researchers and industry professionals across a broad spectrum of specialties working on pathways of immunity and inflammation at barrier surfaces. They rely on Mucosal Immunology for the very latest robust, cutting-edge original research and reviews in basic, translational and clinical science.

The journal has earned a strong reputation for publishing papers based on the quality of the science, its rapid and rigorous peer review, and its contributions to advancing the field. This is demonstrated by its impressive 2021 Journal Impact Factor of 8.701* and a steadily increasing online and social media community.

 

Ben Marsland, PhD
Ben Marsland, PhD

 

“The editorial board and I are tremendously excited for the opportunity to partner with Elsevier to publish Mucosal Immunology,” said Professor Marsland. “I have every confidence that support from the Elsevier team will foster even greater success in our ongoing efforts to publish novel, transformative, and clinically relevant science. On behalf of Mucosal Immunology’s editors, editorial staff, reviewers, and authors, I want to welcome our new partner.

Ben Marsland, PhD

Elsevier is firmly committed to the continuity of the journal’s rigorous editorial process and accessibility of content, and further solidifying Mucosal Immunology’s reputation.

“We are delighted that SMI has selected Elsevier as its publishing partner. By combining their expertise with Elsevier’s industry-leading resources for authors, editors, peer reviewers and readers, we will ensure the best possible support for SMI’s mission and community. By working together, we can achieve a more inclusive, collaborative and transparent world of research,” stated Louise Curtis, Senior Vice President, Life Sciences & Social Sciences, at Elsevier.

Mucosal Immunology is a great asset to the Elsevier immunology journal portfolio, and we look forward to helping the society and their journal navigate a successful transition to full open access status,” added Jenny Henzen, Elsevier’s Publisher for Immunology.

*Journal Citation Reports, Clarivate, 2022

About Mucosal Immunology

Mucosal Immunology is the official publication of the Society for Mucosal Immunology (SMI). It aims to provide a forum for both basic and clinical scientists to discuss all aspects of immunity and inflammation involving barrier tissues. The journal reflects the interests of scientists studying gastrointestinal, pulmonary, nasopharyngeal, oral, ocular, genitourinary and skin immunology through the publication of original research articles, scholarly reviews, and timely commentaries. Publication of basic, translational, and clinical studies are given equal consideration. In addition, Mucosal Immunology aims to provide a primary method of communication for the SMI governing board and its members through the publication of society news, announcements of planned meetings and conferences, discussions of policy concerns, and advertisements for job and training opportunities. Beginning January 2023, all articles will be published as gold open access through CC BY licenses.

About the Society for Mucosal Immunology (SMI)

The Society for Mucosal Immunology was formed in 1987 to advance research and education related to the field of mucosal immunology. With a mission to support research and education, and foster communication and collaboration in the field of mucosal immunology, the society represents a diverse group of over 700 scientists and clinicians from all over the world. https://www.socmucimm.org

About the Editor-in-Chief

 Ben Marsland completed his PhD in Immunology at Otago University and the Malaghan Institute of Medical Research, Wellington, New Zealand. He then spent 14 years in Switzerland, first at the ETH Zürich and then as a Cloetta Medical Research Fellow at the University Hospital of Lausanne (CHUV). During that period, he received the ETH Latsis Prize, the Leenaards Prize and the ERS COPD Research Award. Since 2018, Ben is a veski innovation fellow, NHMRC Senior Research Fellow and Professor in the Department of Immunology and Pathology within the Central Clinical School at Monash University. He also maintains a visiting professorship at the University of Lausanne and CHUV. The focus of Ben’s lab revolves around the microbiome in the gut, lung and skin and how it influences asthma, respiratory viral infections and lung fibrosis.

About Elsevier and society partnerships

Elsevier has long-standing partnerships with over 600 learned societies worldwide, helping them to realize their missions and inspire and support their communities. We pride ourselves on consistently delivering outstanding publishing outcomes through strategic insight, reliable finances, global dissemination, embracing open science and open access, and championing the needs of the communities we jointly serve. www.elsevier.com/societies

About Elsevier

As a global leader in information and analytics, Elsevier helps researchers and healthcare professionals advance science and improve health outcomes for the benefit of society. We do this by facilitating insights and critical decision-making for customers across the global research and health ecosystems.

In everything we publish, we uphold the highest standards of quality and integrity. We bring that same rigor to our information analytics solutions for researchers, health professionals, institutions and funders.

Elsevier employs 8,700 people worldwide. We have supported the work of our research and health partners for more than 140 years. Growing from our roots in publishing, we offer knowledge and valuable analytics that help our users make breakthroughs and drive societal progress. Digital solutions such as ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath support strategic research management, R&D performance, clinical decision support, and health education. Researchers and healthcare professionals rely on our over 2,700 digitized journals, including The Lancet and Cell; our over 43,000 eBook titles; and our iconic reference works, such as Gray's Anatomy. With the Elsevier Foundation and our external Inclusion & Diversity Advisory Board, we work in partnership with diverse stakeholders to advance inclusion and diversity in science, research and healthcare in developing countries and around the world.

Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. www.elsevier.com

 

Contact Details

 

Elsevier

 

Jenny Henzen, Publisher, Immunology

 

j.henzen@elsevier.com

 

Company Website

 

https://www.elsevier.com/

project media
project media

Tags

ElsevierSociety for Mucosal ImmunologyMucosal ImmunologySMIScienceDirectBen Marsland